Ethical Considerations and Risks in Psychiatric Genetics: Preliminary Findings of a Study on Psychiatric Genetic Researchers

AJOB Primary Research

Volumn 2, Issue 4, 2011, Pages 52-60

  Erickson, Jessica ^a   Cho, Mildred ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ethical concerns; psychiatric disorders; psychiatric genetic researchers; risks

Indexed keywords

EID: 84859381958     PISSN: 21507716     EISSN: 21507724     Source Type: Journal    
DOI: 10.1080/21507716.2011.628958     Document Type: Article

References (36)

1. Berg, C. and Fryer-Edwards, K. 2008. The ethical challenges of direct-to-consumer genetic testing. Journal of Business Ethics, 77: 17-31.
2. Braff, D. L. and Freedman, R. 2008. Clinically responsible genetic testing in neuropsychiatric patients: A bridge too far and too soon. American Journal of Psychiatry, 165: 952-955.
3. Caspi, A., Hariri, A. R., Holmes, A., Uher, R. and Mofitt, T. 2010. Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. American Journal of Psychiatry, 167: 509-527.
4. Condit, C. M. 2010. Public understanding of genetics and health. Clinical Genetics, 71: 1-9.
5. Couzin, J. 2008. Science and commerce: Gene tests for psychiatric risk polarize researchers. Science Magazine, 319: 274-277.
6. Craddock, C. S., Daly, M.Faraone, S. V. 2009. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. American Journal of Psychiatry, 166: 540-556.
7. Finn, C. T., Wilcox, M. A.Korf, B. R. 2005. Psychiatric genetics: A survey of psychiatrists' knowledge, opinions, and practice patterns. Journal of Clinical Psychiatry, 66(7): 821-830.
8. Fleising, U. 2001. Genetic essentialism, mana and the meaning of DNA. New Genetics and Society, 20(1): 43-57.
9. Hirschhorn, J. N. 2009. Genomewide association studies-Illuminating biologic pathways. New England Journal of Medicine, 360(17): 1699-701.
10. Hoop, J. G., Lapid, M. I., Paulson, R. M. and Roberts, L. W. 2010. Clinical and ethical considerations in pharmacogenetic testing: Views of physicians in 3 "early adopting" departments of psychiatry. Journal of Clinical Psychiatry, 71: 745-753.
11. Hoop, J. G., Roberts, L. W., Hammond, K. A. G. and Cox, N. J. 2008. Psychiatrists' attitudes regarding genetic testing and patient safeguards: A preliminary study. Genetic Testing, 12: 245-252.
12. Hoop, J. G., Roberts, L. W., Hammond, K. A. G. and Cox, N. J. 2008. Psychiatrists' attitudes, knowledge, and experience regarding genetics: A preliminary study. Genetics in Medicine, 10(6): 439-449.
13. Hoop, J. G., Salva, G., Roberts, L. W., Zisook, S. and Dunn, L. B. 2010. The current state of genetics training in psychiatric residency: Views of 235 U.S. educators and trainees. Academic Psychiatry, 34(2): 109-114.
14. Jordan, B. R. and Tsai, D. F. C. 2010. Whole-genome association studies for multigenic diseases: Ethical dilemmas arising from commercialization-The case of genetic testing for autism. Journal of Medical Ethics, 36: 440-444.
15. Kao, C., Fang, Y., Zhao, Z. and Kuo, P. 2011. Prioritization and evaluation of depression candidate genes by combining multidimensional data resources. PLoS ONE, 6(4): e18696 doi:doi: 10.1371/journal.pone.0018696
16. Kessler, R. C., Berglund, P.Demler, O. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62: 593-602.
17. Kraft, P. and Hunter, D. J. 2009. Genetic risk prediction-Are we there yet?. New England Journal of Medicine, 360(17): 1701-1703.
18. Laegsgaard, M. M., Stamp, A. S., Hall, E. O. and Mors, O. 2010. The perceived and predicted implications of psychiatric genetic knowledge among persons with multiple cases of depression in the family. Acta Psychiatrica Scandinavica, 122(6): 470-480.
19. Laegsgaard, M. M., Kristensen, A. S. and Mors, O. 2009. Potential consumers' attitudes toward psychiatric genetic research and testing and factors influencing their intentions to test. Genetic Testing, 13: 1-9.
20. Laegsgaard, M. M. and Mors, O. 2007. Psychiatric genetic testing: Attitudes and intentions among future users and providers. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B: 375-384.
21. Lake, C. R. and Baumer, J. 2010. Academic psychiatry's responsibility for increasing the recognition of mood disorders and risk for suicide in primary care. Current Opinion in Psychiatry, 23: 157-166.
22. Lau, J. Y. F. and Eley, T. C. 2010. The genetics of mood disorders. Annual Review of Clinical Psychology, 6: 313-337.
23. McBride, C. M., Wade, C. H. and Kaphingst, K. A. 2010. Consumers' views of direct-to-consumer genetic information. Annual Review of Genomics and Human Genetics, 11: 427-446.
24. Mesier, B., Kasparian, N. A.Mitchell, P. B. 2008. Attitudes to genetic testing in families with multiple cases of bipolar disorder. Genetic Testing, 12: 233-244.
25. Merikangas, K., Akiskal, H.Angst, J. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry, 64(5): 543-552.
26. Mitchell, P. B., Meiser, B.Wilde, A. 2010. Predictive and diagnostic genetic testing in psychiatry. Clinics in Laboratory Medicine, 30: 829-846.
27. Molster, C., Charles, T., Samenek, A. and O'Leary, P. 2009. Australian study on public knowledge of human genetics and health. Public Health Genomics, 12: 84-91.
28. Saha, S., Chant, D., Welham, J. and McGrath, J. 2005. A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2: 413-433.
29. Saukko, P. M., Ellard, S., Richards, S. H., Shepherd, M. H. and Campbell, J. L. 2007. Patients' understanding of genetics susceptibility testing in mainstream medicine: Qualitative study on thrombophilia. BMC Health Services Research, 7: 82
30. Spriggs, M., Olsson, C. A. and Hall, W. 2008. How will information about the genetic risk of mental disorders impact on stigma?. Australian and New Zealand Journal of Psychiatry, 42: 214-220.
31. Vicente, B., Kohn, R.Rioseco, P. 2006. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. American Journal of Psychiatry, 163: 1362-1370.
32. Wilde, A., Meiser, B., Mitchel, P. B. and Schofield, P. R. 2011. Community attitudes to genetic susceptibility-based mental health interventions for healthy people in a large national sample. Journal of Affective Disorders, 134: 280-287.
33. Wilde, A., Meiser, B., Mitchel, P. B. and Schofield, P. R. 2010. Public interest in predictive genetic testing, including direct-to-consumer testing, for susceptibility to major depression: Preliminary findings. European Journal of Human Genetics, 18: 47-51.
34. Wilde, A., Meiser, B., Mitchell, P. B. and Schofield, P. R. 2009. Community attitudes towards mental health interventions for healthy people on the basis of genetic susceptibility. Australian and New Zealand Journal of Psychiatry, 43: 1070-1076.
35. Wright, C. F. and Kroese, M. 2010. Evaluation of genetic tests for susceptibility to common complex diseases: Why, when and how?. Human Genetics, 127: 125-134.
36. Zhang, F., Chen, Q.Ye, T. 2011. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biological Psychiatry, 10: 914-917.